Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Anesthesia methods, neuroprotection, and surgical field in FESS with controlled hypotension

Official title: FUNCTIONAL ENDOSCOPIC NASAL AND SINUS SURGERY AND ANESTHESIA: Study of Hemodynamic Parameters During General Anesthesia Compared to the Surgical Field, as Well as Assessment of Cerebral Ischemia Intraoperatively by Measurement of S100B Protein and Specific Neuronal Enolase (NSE).

Run by University General Hospital of Patras · NCT07181564 · Data updated 2026-11-12

This trial tests whether four different anesthesia maintenance techniques — propofol-remifentanil, propofol-remifentanil with ketamine and magnesium, sevoflurane-remifentanil, and sevoflurane-remifentanil with ketamine and magnesium — better protect the brain and improve the surgical field in adults having FESS under controlled hypotension.

More Ketamine trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment150 (estimated)
SponsorUniversity General Hospital of Patras
Academic / other
Locations1 site (Pátrai, Achaia)
StatusRecruiting
StartedSeptember 11, 2025
Main results expectedFebruary 2, 2026
Study endsMarch 20, 2026
Registry record updatedSeptember 18, 2025
Trial IDNCT07181564 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) scheduled for elective FESS under general anesthesia who can give informed consent and do not have severe hepatic or renal dysfunction, pregnancy, or contraindications to the study drugs are ideal candidates.

Probably not a fit

Patients having emergency surgery, with ASA IV–V, severe hepatic or renal failure, pregnancy or lactation, known allergy to study drugs, or inability to consent would not be eligible and thus would not receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-center randomized trial enrolls adult patients undergoing elective functional endoscopic sinus surgery (FESS) under controlled hypotension and randomizes them to one of four anesthesia maintenance regimens: propofol-remifentanil, propofol-remifentanil plus continuous ketamine and magnesium, sevoflurane-remifentanil, or sevoflurane-remifentanil plus continuous ketamine and magnesium. Primary outcomes are serum biomarkers of neuronal injury (S100B and neuron-specific enolase) measured at baseline, 20 minutes after initiation of controlled hypotension, and at the end of surgery, alongside blinded surgeon ratings of surgical field visibility and intraoperative bleeding. Secondary outcomes include extubation conditions measured by the Aldrete score, postoperative pain by visual analogue scale, and recovery profile. The trial examines whether adjunct ketamine and magnesium provide added neuroprotection during periods of controlled hypotension while maintaining hemodynamic stability and acceptable surgical conditions.

Why it matters

Potential benefit: If successful, adding ketamine and magnesium could lower markers of neuronal injury, reduce bleeding and improve surgical visibility and recovery for patients having FESS under hypotension.

How similar studies have gone: Some prior studies suggest ketamine and magnesium may have neuroprotective or anesthetic-sparing effects in other surgical contexts, but evidence in FESS under controlled hypotension is limited and mixed, making this application relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria :

Adult patients (≥18 years old). Scheduled for F.E.S.S (Functional endoscopic sinus surgery ) under general anesthesia.

Able to provide informed consent

Exclusion Criteria:

Emergency surgery. ASA physical status IV-V. Severe hepatic or renal dysfunction. Known allergy or contraindication to study drugs. Pregnant or lactating women. unable to provide informed consent

Patients unwilling or unable to provide consent.

Where it's running

  • University General Hospital of Patras
    Pátrai, Achaia, Greece
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.